Researcher
Marc Peeters
- Research Expertise (University of Antwerp):My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical studies
- Keywords (University of Antwerp):ONCOLOGY, Medicine
- Disciplines (Ghent University):Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
- Disciplines (University of Antwerp):Cancer therapy, Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention
- Research techniques (University of Antwerp):Making protocols for studies. (Statistical) analysis of results
- Users of research expertise (University of Antwerp):Other researchers in the field. Students Pharma and Biotech companies
- See also: Marc Peeters (Ghent University)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Responsible
From1 Oct 2009 → 31 Dec 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 10 of 67
- Dawn of a new era in drug discovery: the symphony of AI-guided small molecule design with 3D patient-derived tumor organoids.From1 Jan 2024 → TodayFunding: IOF - technology concept exploration
- Trapped ion mobility quadrupole time of flight mass spectrometer hyphenated to automated high throughput liquid chromatography.From30 Jun 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Neuroendocrine neoplasms from bench to bedside: unravelling personalised strategies through the integration of clinical data and patientderived organoids.From1 Mar 2023 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Detection and quantification of a panel of clinically relevant DNA biomarker sequences containing KRAS mutations in tissue and liquid biopsies via a novel photoelectrochemical technology.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Multiplexed photoelectrochemical detection technology for molecular cancer biomarkers (MultiSens).From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology validation in lab
- A new photoelectrochemical singlet oxygen-based detection platform for a panel of cancer biomarkers in tissue and liquid biopsies (SOCAN).From1 Jan 2023 → TodayFunding: BOF - iBOF, University - Project driven research
- Improving diagnostic accuracy and follow-up of neuroendocrine neoplasms through detection of (epi)genetic biomarkers in liquid biopsies using novel technological platforms.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- Towards informed decisions in colorectal cancer screening (ORIENT).From15 Aug 2022 → TodayFunding: Nonprofit institution or equivalents
- Center for Proteomics (CfP).From1 Jan 2022 → TodayFunding: BOF - research organisations
Publications
11 - 20 of 385
- Investigation on cellular senescence in non-small cell lung cancer(2023)
Authors: An Wouters, Marc Peeters
Number of pages: 191 - Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer(2023)
Authors: Maxim Le Compte, Edgar Cardenas, Sofía Peeters, Felicia Rodrigues Fortes, Christophe Hermans, Evelien Smits, Filip Lardon, Timon Vandamme, Abraham Lin, Steve Vanlanduit, et al.
Pages: 1 - 14 - Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs(2023)
Authors: Katleen Janssens, Isabelle Neefs, Joe Ibrahim, Anne Schepers, Patrick Pauwels, Marc Peeters, Guy Van Camp, Ken Op de Beeck
Pages: 1 - 14 - The impact of a six-year existing screening programme using the faecal immunochemical test in Flanders (Belgium) on colorectal cancer incidence, mortality and survival(2023)
Authors: Thuy Ngan Tran, Sarah Hoeck, Harlinde De Schutter, Sharon Janssens, Marc Peeters, Guido Van Hal
Pages: 1 - 17 - Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity(2023)
Authors: Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Jöran Melis, Valentin van den Bossche, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Céline Merlin, Cyril Corbet, et al.
Pages: 709 - 728 - Novel therapeutic strategies in pancreatic cancer(2023)
Authors: Barbara Geerinckx, Laure-Anne Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Price
Pages: 1237 - 1249 - Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer(2023)
Authors: Yana Debie, Jonas Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Maria Goossens, et al.
Pages: 635 - 646 - Boosting capacity of a fourth dose BNT162b2 in cancer patients(2023)
Authors: Yana Debie, Peter Van Dam, Maria Goossens, Marc Peeters, Timon Vandamme
Pages: 121 - 123 - Liquid biopsies in metastatic breast cancer(2023)
Authors: Aaltje Brouwer, Marc Peeters, Steven Van Laere, Luc Dirix, Emma Beddowes
Number of pages: 154 - Singlet oxygen-based photoelectrochemical detection of single-point mutations in the KRAS oncogene(2023)
Authors: Elise Daems, Simone Bassini, Laura Mariën, Hannah Op de Beeck, Alexandr Stratulat, Karen Zwaenepoel, Timon Vandamme, Ken Op de Beeck, Senada Koljenovic, Marc Peeters, et al.
Pages: 1 - 7
Patents
1 - 6 of 6
- Combination immunotherapy of il-15 and cd40 agonist in cancer treatment (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation detection assay (Inventor)
- Methylation status of gasdermin E gene as cancer biomarker (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation status of gasdermin e gene as cancer biomarker (Inventor)